Sports Medicine Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Sports Medicine Market was valued at USD 6.1 billion in 2022 and is estimated to reach USD 11.1 billion by 2032. It is a branch of medicine that deals with the prevention, diagnosis, treatment, and rehabilitation of injuries related to sports and exercise.
The primary focus is to optimize the performance of athletes and individuals engaged in physical activity, as well as to promote overall health and fitness. During the Winter Olympic Games in Beijing 2022, the medical staff reported a total of 725 injuries and 1,119 illnesses. This corresponds to an incidence of 24 injuries and 31 illnesses per 1000 athletes and nonathletes. Overall, 2.4% of the participants experienced at least one injury, while 3.1% had at least one illness. Consequently, a high incidence of such sports injuries could potentially drive market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Sports Medicine Market Size in 2022: | USD 6.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 6.2 |
2023 Value Projection: | USD 11.1 Billion |
Historical Data for: | 2018 to 2022 |
No of Pages: | 250 |
Tables, Charts & Figures: | 415 |
Segments Covered: | Product, Injury Type, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Moreover, the market is anticipated to experience growth due to the increasing awareness regarding personal health and substantial rise in government initiatives promoting sports activities. The surge in sports participation is likely to result in a higher incidence of sports injuries. Additionally, advancements in the orthopedic devices, such as the adoption of technologies such as 3D printed medical devices & implants, introduction of bionic and sensor technology in prosthetic limbs, is poised to provide unprecedented growth opportunities for expansion of the sports medicine industry.
During COVID-19 pandemic, sports medicine market encountered a setback due to deferral and cancellation of range of sports events that led to decline in sports injuries. In March 2020, Tokyo Olympics and Paralympics was postponed to 2021 by the International Olympic Committee. Such incidents negatively impacted the growth of market. The medical professionals and specialists were instructed to address only the emergency and critical surgical operations during this period. All these factors affected product sales with declined hospital visits during the initial phase of the pandemic.
The growth of the market is further propelled by the increasing preference for minimally invasive technologies, particularly in developed countries. The advantages associated with minimally invasive procedures include shorter hospital stay, quicker recovery, and effective post-surgical pain management, driving the demand for these procedures, and positively influencing market development.
The market by product is categorized into body reconstruction products, body support & recovery, accessories, and others. The body reconstruction products segment is bifurcated into orthopedic implants, fracture and ligament repair products, arthroscopy devices, soft tissue repair products, prosthetics, orthobiologics. This segment garnered USD 3.5 billion revenue size in the year 2022.
Based on injury type, the sports medicine market is segmented into knee, shoulder, foot and ankle, back and spine, hip and groin, and other injuries. The foot and ankle injuries segment dominated the market and accounted for over 18.4% business share in the year 2022.
Based on end-use, the sports medicine market is segmented into hospitals, ambulatory surgical centres, physiotherapy centers, and other end-users. The hospitals segment dominated the sports medicine market and accounted for over 52% business share in the year 2022.
U.S. sports medicine market accounted for over USD 800 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
Moreover, developed healthcare infrastructure coupled with increasing adoption of technologically advanced devices to treat sports injuries are some of the key factors driving the market development.
The sports medicine industry is fragmented, with key players including Stryker Corporation, Smith & nephew and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in March 2023, Smith & Nephew, unveiled QUADTRAC System representing the inaugural integrated guide system designed for minimally invasive quadriceps graft harvesting. This innovative system facilitates direct visualization of the tendon, offering a controlled and reproducible technique for the harvesting process. This new addition aimed at expanding the product portfolio and enhance overall company's revenue.
Some of the eminent market participants operating in the sports medicine industry include:
By Product, 2018 – 2032 (USD Million)
By Injury Type, 2018 – 2032 (USD Million)
By End-use, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries:
Sports medicine industry from the body reconstruction products segment accounted for USD 3.5 billion in revenue in 2022 and is estimated to witness high demand driven by the growing focus on new product development revolutionizing implant placement technologies.
U.S. sports medicine market size surpassed USD 800 million in revenue in 2022 and set to depict robust growth through 2032 owing to the presence of major players, favorable reimbursement scenarios coupled with the rising number of medical centers, and growing investment in the development of sports medicine.
Sports medicine industry size was worth USD 6.1 billion in 2022 and is expected to reach USD 11.1 billion by 2032 owing to a high incidence of sports injuries.
The top companies in the market are Stryker Corporation, Arthrex, Inc., Otto Bock Healthcare, Zimmer Biomet, Smith & Nephew Plc, Performance Health International Limited, Johnson & Johnson, and Anika Therapeutics, Inc., among others.